204 related articles for article (PubMed ID: 23069586)
1. Aged garlic extract inhibits platelet activation by increasing intracellular cAMP and reducing the interaction of GPIIb/IIIa receptor with fibrinogen.
Allison GL; Lowe GM; Rahman K
Life Sci; 2012 Dec; 91(25-26):1275-80. PubMed ID: 23069586
[TBL] [Abstract][Full Text] [Related]
2. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
[TBL] [Abstract][Full Text] [Related]
3. Aged Garlic Extract Inhibits Human Platelet Aggregation by Altering Intracellular Signaling and Platelet Shape Change.
Rahman K; Lowe GM; Smith S
J Nutr; 2016 Feb; 146(2):410S-415S. PubMed ID: 26764324
[TBL] [Abstract][Full Text] [Related]
4. Modulation of platelet-neutrophil interaction with pharmacological inhibition of fibrinogen binding to platelet GPIIb/IIIa receptor.
Xiao Z; Théroux P; Frojmovic M
Thromb Haemost; 1999 Feb; 81(2):281-5. PubMed ID: 10064007
[TBL] [Abstract][Full Text] [Related]
5. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of fibrinogen binding and surface recruitment of GpIIb/IIIa as dose-dependent effects of the RGD-mimetic MK-852.
Wittig K; Rothe G; Schmitz G
Thromb Haemost; 1998 Mar; 79(3):625-30. PubMed ID: 9531053
[TBL] [Abstract][Full Text] [Related]
7. Evidence for platelet alphaIIb beta3 activation despite elevated cytosolic cAMP.
Riondino S; Gazzaniga PP; Pulcinelli FM
Thromb Haemost; 2001 Feb; 85(2):320-5. PubMed ID: 11246555
[TBL] [Abstract][Full Text] [Related]
8. A novel anti-platelet peptide (Z4A5) potential for glycoprotein IIb/IIIa inhibits platelet aggregation.
Li YX; Sun Q; Zhang H; Ren ST; Liao YR; Wang Y; Shen XL; Wang B
Thromb Res; 2012 May; 129(5):e217-22. PubMed ID: 22445430
[TBL] [Abstract][Full Text] [Related]
9. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.
Cook NS; Zerwes HG; Tapparelli C; Powling M; Singh J; Metternich R; Hagenbach A
Thromb Haemost; 1993 Sep; 70(3):531-9. PubMed ID: 8259560
[TBL] [Abstract][Full Text] [Related]
10. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein.
Shido K; Ahmad G; Hsu L; Kamiyama M
J Clin Lab Immunol; 1995; 46(1):1-11. PubMed ID: 9363587
[TBL] [Abstract][Full Text] [Related]
11. MK-383 (tirofiban) induces a GPIIb/IIIa receptor conformation which differs from the resting and activated receptor.
Barlage S; Wimmer A; Pfeiffer A; Rothe G; Schmitz G
Platelets; 2002 May; 13(3):133-40. PubMed ID: 12180495
[TBL] [Abstract][Full Text] [Related]
12. Platelets from bleeding Simmental cattle have a long delay in both ADP-activated expression of GpIIB-IIIA receptors and fibrinogen-dependent platelet aggregation.
Frojmovic MM; Wong T; Searcy GP
Thromb Haemost; 1996 Dec; 76(6):1047-52. PubMed ID: 8972030
[TBL] [Abstract][Full Text] [Related]
13. Interactions of platelets with Synthocytes, a novel platelet substitute.
Davies AR; Judge HM; May JA; Glenn JR; Heptinstall S
Platelets; 2002 Jun; 13(4):197-205. PubMed ID: 12189020
[TBL] [Abstract][Full Text] [Related]
14. A defined peptide that inhibits the formation of the glycoprotein IIb and IIIa complex.
Chiang TM; Zhu J
Thromb Res; 2005; 115(6):503-8. PubMed ID: 15792682
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
[TBL] [Abstract][Full Text] [Related]
16. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
Wang WY; Wu YC; Wu CC
Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
[TBL] [Abstract][Full Text] [Related]
17. Effects of garlic on platelet biochemistry and physiology.
Rahman K
Mol Nutr Food Res; 2007 Nov; 51(11):1335-44. PubMed ID: 17966136
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. I. Quantal activation of platelet subpopulations varies with adenosine diphosphate concentration.
Frojmovic MM; Mooney RF; Wong T
Biophys J; 1994 Nov; 67(5):2060-8. PubMed ID: 7858143
[TBL] [Abstract][Full Text] [Related]
19. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease.
Kaplan R; Gabbeta J; Sun L; Mao GF; Rao AK
Br J Haematol; 2000 Dec; 111(3):954-64. PubMed ID: 11122160
[TBL] [Abstract][Full Text] [Related]
20. Gender differences in platelet GPIIb-IIIa activation.
Faraday N; Goldschmidt-Clermont PJ; Bray PF
Thromb Haemost; 1997 Apr; 77(4):748-54. PubMed ID: 9134654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
